Pacira BioSciences (PCRX)

Pacira BioSciences (PCRX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• PCRX last traded at $36.40, 0.03% on the day.
• Pacira BioSciences: market cap $1.45B, P/E 103.4, revenue $746.16M over the last four quarters, next earnings 2026-11-05.
• Over the past year PCRX returned 70.25%; year to date 40.65%.

Updated 2026-11-03 11:30 UTC